Elevance Health may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Elevance Health's Retained Earnings are fairly stable compared to the past year. Accounts Payable is likely to climb to about 23.8 B in 2025, whereas Total Stockholder Equity is likely to drop slightly above 24.4 B in 2025. Key indicators impacting Elevance Health's financial strength include:
Investors should never underestimate Elevance Health's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Elevance Health's cash flow, debt, and profitability to make informed and accurate decisions about investing in Elevance Health.
Cash And Equivalents
5.43 Billion
Elevance
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Net Income Per Share
Payables Turnover
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Change To Account Receivables
Sale Purchase Of Stock
Dividends Paid
Change To Inventory
Total Cashflows From Investing Activities
Investments
Change Receivables
Net Borrowings
Exchange Rate Changes
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Operating Activities
Total Assets
Short Long Term Debt Total
Total Stockholder Equity
Net Debt
Other Assets
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Stockholder Equity
Total Liab
Other Current Liab
Total Current Liabilities
Other Liab
Retained Earnings
Accounts Payable
Cash
Long Term Debt
Short Term Investments
Other Current Assets
Intangible Assets
Property Plant Equipment
Property Plant And Equipment Net
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Common Stock Total Equity
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Common Stock
Current Deferred Revenue
Good Will
Inventory
Noncontrolling Interest In Consolidated Entity
Retained Earnings Total Equity
Deferred Long Term Liab
Net Tangible Assets
Long Term Debt Total
Capital Surpluse
Long Term Investments
Non Current Liabilities Other
Short Long Term Debt
Cash And Equivalents
Net Invested Capital
Interest Expense
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Total Operating Expenses
Income Tax Expense
Cost Of Revenue
Income Before Tax
Net Income Applicable To Common Shares
Minority Interest
Depreciation And Amortization
Selling General Administrative
Total Other Income Expense Net
Selling And Marketing Expenses
Net Income From Continuing Ops
Tax Provision
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Elevance Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Elevance Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Elevance Health's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Elevance Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Elevance Health. Check Elevance Health's Beneish M Score to see the likelihood of Elevance Health's management manipulating its earnings.
Elevance Health Stock Summary
Elevance Health competes with Cigna Corp, UnitedHealth Group, Centene Corp, Molina Healthcare, and Humana. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana. Elevance Health operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 98200 people.
The reason investors look at the income statement is to determine what Elevance Health's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Elevance Health's current stock value. Our valuation model uses many indicators to compare Elevance Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elevance Health competition to find correlations between indicators driving Elevance Health's intrinsic value. More Info.
Elevance Health is rated # 3 in return on equity category among its peers. It also is rated # 3 in return on asset category among its peers reporting about 0.34 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Elevance Health is roughly 2.90 . At this time, Elevance Health's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Elevance Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Elevance Health Systematic Risk
Elevance Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Elevance Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Elevance Health correlated with the market. If Beta is less than 0 Elevance Health generally moves in the opposite direction as compared to the market. If Elevance Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Elevance Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Elevance Health is generally in the same direction as the market. If Beta > 1 Elevance Health moves generally in the same direction as, but more than the movement of the benchmark.
Elevance Health Thematic Clasifications
Elevance Health is part of Insurance investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Insurance industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Insurance industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Elevance Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Elevance Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Elevance Health growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Elevance Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Elevance Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Elevance Health based on widely used predictive technical indicators. In general, we focus on analyzing Elevance Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Elevance Health's daily price indicators and compare them against related drivers.
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.